N. Sanuki

发表

The maximum standardized uptake value (SUVmax) on FDG-PET is a strong predictor of local recurrence for localized non-small-cell lung cancer after stereotactic body radiotherapy (SBRT).

Toshio Ohashi, Etsuo Kunieda, Hirofumi Fujii, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Phase 2 study of stereotactic body radiotherapy and optional transarterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and radiofrequency ablation

E. Kunieda, H. Saito, H. Ebinuma, 2016, Cancer.

Reassessment of declines in pulmonary function ≥1 year after stereotactic body radiotherapy.

E. Kunieda, A. Takeda, N. Sanuki, 2013, Chest.

Salvage stereotactic ablative irradiation for isolated postsurgical local recurrence of lung cancer.

E. Kunieda, T. Kaneko, A. Takeda, 2013, The Annals of thoracic surgery.

Comparison of clinical, tumour-related and dosimetric factors in grade 0-1, grade 2 and grade 3 radiation pneumonitis after stereotactic body radiotherapy for lung tumours.

E. Kunieda, T. Enomoto, N. Shigematsu, 2012, The British journal of radiology.

Acute exacerbation of subclinical idiopathic pulmonary fibrosis triggered by hypofractionated stereotactic body radiotherapy in a patient with primary lung cancer and slightly focal honeycombing

E. Kunieda, K. Sayama, A. Takeda, 2008, Radiation Medicine.

Dose distribution analysis of axillary lymph nodes for three-dimensional conformal radiotherapy with a field-in-field technique for breast cancer.

N. Shigematsu, T. Ohashi, J. Fukada, 2008, International journal of radiation oncology, biology, physics.

Toxicities of Organs at Risk in the Mediastinal and Hilar Regions Following Stereotactic Body Radiotherapy for Centrally Located Lung Tumors

E. Kunieda, N. Shigematsu, A. Takeda, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Clarithromycin mitigates radiation pneumonitis in patients with lung cancer treated with stereotactic body radiotherapy.

E. Kunieda, M. Shinkai, Y. Hara, 2018, Journal of thoracic disease.

Stereotactic body radiotherapy for lung cancer patients with idiopathic interstitial pneumonias.

E. Kunieda, Y. Hara, T. Kaneko, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Axillary Irradiation with High Tangent Fields for Clinically Node-Negative Breast Cancer: Can 3-D Conformal Radiotherapy with a Field-in-Field Technique Better Control the Axilla?

E. Kunieda, A. Takeda, N. Sanuki, 2013, Breast Care.

Outcomes of clinically node-negative breast cancer without axillary dissection: can preserved axilla be safely treated with radiation after a positive sentinel node biopsy?

E. Kunieda, A. Takeda, N. Sanuki, 2013, Clinical breast cancer.

Radiotherapy quality assurance review for a multi-center randomized trial of locally advanced esophageal cancer: the Japan Clinical Oncology Group (JCOG) trial 0303

M. Shinoda, K. Hayakawa, N. Sanuki, 2012, International Journal of Clinical Oncology.

Questionnaire survey comparing surgery and stereotactic body radiotherapy for lung cancer: lessons from patients with experience of both modalities.

N. Horita, E. Kunieda, M. Taguri, 2019, Journal of thoracic disease.

Tumor response on CT following hypofractionated stereotactic ablative body radiotherapy for small hypervascular hepatocellular carcinoma with cirrhosis.

E. Kunieda, A. Takeda, N. Sanuki, 2013, AJR. American journal of roentgenology.

Stereotactic body radiotherapy for T3 and T4N0M0 non–small cell lung cancer

N. Shigematsu, A. Takeda, N. Sanuki, 2016, Journal of radiation research.

Substantial imbalance that is never eliminated with propensity score matched analyses in comparing surgery to stereotactic body radiotherapy for patients with early-stage non-small cell lung cancer.

A. Takeda, N. Sanuki, Y. Tsurugai, 2019, Journal of thoracic disease.

Applying Artificial Neural Networks to Develop a Decision Support Tool for Tis–4N0M0 Non–Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy

E. Kunieda, Y. Matsuo, N. Shigematsu, 2022, JCO clinical cancer informatics.

Stereotactic body radiotherapy for chronic obstructive pulmonary disease patients undergoing or eligible for long-term domiciliary oxygen therapy

M. Shinkai, Y. Hara, T. Kaneko, 2015, Journal of radiation research.

Association of computed tomography-detected pulmonary interstitial changes with severe radiation pneumonitis for patients treated with thoracic radiotherapy.

N. Sanuki, S. Akamine, Noritaka Kamei, 2012, Journal of radiation research.

Acceptable toxicity after stereotactic body radiation therapy for liver tumors adjacent to the central biliary system.

E. Kunieda, N. Shigematsu, A. Takeda, 2013, International journal of radiation oncology, biology, physics.

Possible misinterpretation of demarcated solid patterns of radiation fibrosis on CT scans as tumor recurrence in patients receiving hypofractionated stereotactic radiotherapy for lung cancer.

E. Kunieda, N. Shigematsu, H. Fujii, 2008, International journal of radiation oncology, biology, physics.

Role of stereotactic body radiation therapy for hepatocellular carcinoma.

E. Kunieda, A. Takeda, N. Sanuki, 2014, World journal of gastroenterology.

Pleural contact decreases survival in clinical T1N0M0 lung cancer patients undergoing SBRT.

M. Taguri, N. Shigematsu, Y. Hara, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Relationship between Dose Prescription Methods and Local Control Rate in Stereotactic Body Radiotherapy for Early Stage Non-Small-Cell Lung Cancer: Systematic Review and Meta-Analysis

N. Horita, K. Nagashima, A. Takeda, 2022, Cancers.

In Regard to Lee et al.

A. Takeda, N. Sanuki, Takahisa Eriguchi, 2021, International journal of radiation oncology, biology, physics.

Stereotactic body radiotherapy with a high maximum dose improves local control, cancer-specific death and overall survival in peripheral early-stage non-small cell lung cancer.

N. Horita, T. Kaneko, A. Takeda, 2021, International journal of radiation oncology, biology, physics.

Stereotactic body radiotherapy for patients with non-small-cell lung cancer using RapidArc delivery and a steep dose gradient: prescription of 60% isodose line of maximum dose fitting to the planning target volume

E. Kunieda, A. Takeda, N. Sanuki, 2019, Journal of radiation research.

Subclinical interstitial lung disease: is it a risk factor for fatal radiation pneumonitis following stereotactic body radiotherapy?

E. Kunieda, A. Takeda, N. Sanuki, 2014, Lung cancer.

Three Cases of Hepatocellular Carcinoma With Massive Macrovascular Invasion Successfully Treated With Radiotherapy

A. Takeda, N. Sanuki, Y. Tsurugai, 2021, Cureus.

Multicenter prospective study of stereotactic body radiotherapy for previously untreated solitary primary hepatocellular carcinoma: The STRSPH study

T. Kimura, S. Shimizu, M. Kokubo, 2020, Hepatology research : the official journal of the Japan Society of Hepatology.

Influence of liver toxicities on prognosis after stereotactic body radiation therapy for hepatocellular carcinoma

E. Kunieda, A. Takeda, N. Sanuki, 2015, Hepatology research : the official journal of the Japan Society of Hepatology.

Role of stereotactic body radiotherapy in multidisciplinary management of liver metastases in patients with colorectal cancer

A. Takeda, N. Sanuki, Y. Tsurugai, 2022, Japanese Journal of Radiology.

Early graphical appearance of radiation pneumonitis correlates with the severity of radiation pneumonitis after stereotactic body radiotherapy (SBRT) in patients with lung tumors.

E. Kunieda, N. Shigematsu, T. Ohashi, 2010, International journal of radiation oncology, biology, physics.

Dose volume histogram analysis of focal liver reaction in follow-up multiphasic CT following stereotactic body radiotherapy for small hepatocellular carcinoma.

E. Kunieda, T. Ohashi, A. Takeda, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The Japanese Breast Cancer Society Clinical Practice Guideline for radiation treatment of breast cancer, 2018 edition

H. Iwata, M. Yoshimura, K. Sekiguchi, 2019, Breast Cancer.

Comparison of stereotactic body radiotherapy and radiofrequency ablation for hepatocellular carcinoma: Systematic review and meta‐analysis of propensity score studies

N. Horita, H. Ebinuma, A. Takeda, 2021, Hepatology research : the official journal of the Japan Society of Hepatology.

Stereotactic ablative body radiation therapy with dynamic conformal multiple arc therapy for liver tumors: optimal isodose line fitting to the planning target volume.

E. Kunieda, A. Takeda, N. Sanuki, 2014, Practical radiation oncology.

Ablative Radiation Therapy for Early Hepatocellular Carcinoma

A. Takeda, N. Sanuki, Y. Tsurugai, 2021, Radiotherapy of Liver Cancer.

Threshold doses for focal liver reaction after stereotactic ablative body radiation therapy for small hepatocellular carcinoma depend on liver function: evaluation on magnetic resonance imaging with Gd-EOB-DTPA.

E. Kunieda, A. Takeda, N. Sanuki, 2014, International journal of radiation oncology, biology, physics.

Stereotactic body radiotherapy for small hepatocellular carcinoma: A retrospective outcome analysis in 185 patients

E. Kunieda, A. Takeda, N. Sanuki, 2014, Acta oncologica.

Hypofractionated stereotactic radiotherapy with and without transarterial chemoembolization for small hepatocellular carcinoma not eligible for other ablation therapies: Preliminary results for efficacy and toxicity

E. Kunieda, H. Saito, N. Shigematsu, 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

Radiotherapy for Hepatocellular Carcinoma Results in Comparable Survival to Radiofrequency Ablation: A Propensity Score Analysis

Katsuaki Tanaka, A. Takeda, N. Sanuki, 2019, Hepatology.

Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma – benchmark for a prospective multi-institutional study

T. Kimura, Y. Matsuo, A. Takeda, 2013, Radiation oncology.

Stereotactic ablative body radiotherapy for previously untreated solitary hepatocellular carcinoma

E. Kunieda, A. Takeda, N. Sanuki, 2014, Journal of gastroenterology and hepatology.

Stereotactic ablative body radiation therapy for octogenarians with non-small cell lung cancer.

Satoshi Morita, Etsuo Kunieda, Takeshi Kaneko, 2013, International journal of radiation oncology, biology, physics.

Are Head-to-Head Comparisons Between Radiofrequency Ablation and Stereotactic Body Radiotherapy Really Necessary for Localized Hepatocellular Carcinoma?

A. Takeda, N. Sanuki, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Role of stereotactic body radiotherapy for oligometastasis from colorectal cancer.

E. Kunieda, A. Takeda, N. Sanuki, 2014, World journal of gastroenterology.

Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma – benchmark for a prospective multi-institutional study

Y. Matsuo, A. Takeda, N. Sanuki, 2013, Radiation Oncology.

Evaluation for local failure by 18F-FDG PET/CT in comparison with CT findings after stereotactic body radiotherapy (SBRT) for localized non-small-cell lung cancer.

Toshio Ohashi, Etsuo Kunieda, Hirofumi Fujii, 2013, Lung cancer.

Correction to: The Japanese Breast Cancer Society Clinical Practice Guideline for radiation treatment of breast cancer, 2018 edition

H. Iwata, M. Yoshimura, K. Sekiguchi, 2021, Breast Cancer.

Radiation therapy after breast-conserving surgery

E. Kunieda, N. Shigematsu, Hisao Ito, 2006, Radiation Medicine.

The Japanese Breast Cancer Society clinical practice guideline for radiotherapy of breast cancer

H. Mukai, Y. Ogawa, M. Yoshimura, 2014, Breast Cancer.

Local Control Correlates with Overall Survival in Radiotherapy for Early-stage Non-small Cell Lung Cancer: A Systematic Review

N. Horita, A. Takeda, N. Sanuki, 2023, Radiotherapy and Oncology.

Stereotactic body radiotherapy for operable early-stage non-small cell lung cancer.

N. Shigematsu, A. Takeda, N. Sanuki, 2017, Lung cancer.

Dose distribution analysis in stereotactic body radiotherapy using dynamic conformal multiple arc therapy.

E. Kunieda, N. Shigematsu, T. Ohashi, 2009, International journal of radiation oncology, biology, physics.

Stereotactic body radiotherapy (SBRT) for solitary pulmonary nodules clinically diagnosed as lung cancer with no pathological confirmation: comparison with non-small-cell lung cancer.

E. Kunieda, A. Takeda, N. Sanuki, 2012, Lung cancer.

Dose-Escalated Stereotactic Body Radiotherapy (SBRT) as a Salvage Treatment for Two Cases with Relapsed Peripheral Lung Cancer After Initial SBRT.

N. Shigematsu, A. Takeda, N. Sanuki, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Analysis of porcine optineurin and myocilin expression in trabecular meshwork cells and astrocytes from optic nerve head.

S. Noda, N. Shimizu, J. Kudoh, 2004, Investigative ophthalmology & visual science.

Feasibility study of stereotactic body radiotherapy for peripheral lung tumors with a maximum dose of 100 Gy in five fractions and a heterogeneous dose distribution in the planning target volume

E. Kunieda, T. Kaneko, A. Takeda, 2014, Journal of radiation research.

Evaluation of microscopic tumor extension in early-stage cervical cancer: quantifying subclinical uncertainties by pathological and magnetic resonance imaging findings

N. Sanuki, Noritaka Kamei, H. Matsumoto, 2013, Journal of radiation research.

Stereotactic body radiotherapy for patients with oligometastases from colorectal cancer: risk-adapted dose prescription with a maximum dose of 83–100 Gy in five fractions

A. Takeda, N. Sanuki, Y. Tsurugai, 2016, Journal of radiation research.

Radiation Therapy for Malignant Lumbosacral Plexopathy: A Case Series

N. Sanuki, Shuji Kodama, Hideki Watanabe, 2022, Cureus.

Cutaneous metastasis of prostate carcinoma treated with electron radiotherapy

N. Sanuki, H. Matsuura, S. Arase, 2019, IJU case reports.

Symptom palliation with QUAD Shot radiation therapy to penile metastasis derived from descending colon cancer: a case report

Y. Mohri, Takeshi Yokoe, K. Uchida, 2023, International Cancer Conference Journal.

Dynamic conformal arc radiotherapy for locally advanced lung cancer: a comparison with static-beam conformal radiotherapy

N. Sanuki, M. Goto, H. Seta, 2022, Reports of Practical Oncology & Radiotherapy.

Stereotactic body radiotherapy for primary non-small cell lung cancer patients with clinical T3-4N0M0 (UICC 8th edition): outcomes and patterns of failure

T. Kaneko, A. Takeda, N. Sanuki, 2019, Journal of radiation research.

Maximum Standardized Uptake Value on FDG-PET Is a Strong Predictor of Overall and Disease-Free Survival for Non–Small-Cell Lung Cancer Patients after Stereotactic Body Radiotherapy

E. Kunieda, H. Fujii, A. Takeda, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Phase 2 study of stereotactic body radiotherapy and optional transarterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and radiofrequency ablation

E. Kunieda, H. Saito, H. Ebinuma, 2016, Cancer.

Maximum Standardized Uptake Value on FDG-PET Is a Strong Predictor of Overall and Disease-Free Survival for Non–Small-Cell Lung Cancer Patients after Stereotactic Body Radiotherapy

E. Kunieda, H. Fujii, A. Takeda, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Stereotactic body radiotherapy for operable early-stage non-small cell lung cancer.

N. Shigematsu, A. Takeda, N. Sanuki, 2017, Lung cancer.

Salvage stereotactic ablative irradiation for isolated postsurgical local recurrence of lung cancer.

E. Kunieda, T. Kaneko, A. Takeda, 2013, The Annals of thoracic surgery.

Stereotactic body radiotherapy for primary lung cancer at a dose of 50 Gy total in five fractions to the periphery of the planning target volume calculated using a superposition algorithm.

Toshio Ohashi, Naoyuki Shigematsu, Etsuo Kunieda, 2009, International journal of radiation oncology, biology, physics.

Toward consensus reporting of radiation-induced liver toxicity in the treatment of primary liver malignancies: defining clinically relevant endpoints: In Regard to Chapman et al.

N. Sanuki, 2017, Practical radiation oncology.